MARKET

ALRN

ALRN

Aileron Therapeutics Inc
NASDAQ
2.590
+0.010
+0.39%
Opening 14:06 11/22 EST
OPEN
2.610
PREV CLOSE
2.580
HIGH
2.690
LOW
2.400
VOLUME
49.92K
TURNOVER
--
52 WEEK HIGH
7.42
52 WEEK LOW
1.610
MARKET CAP
56.11M
P/E (TTM)
-0.8318
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ALRN last week (1111-1115)?
Weekly Report · 4d ago
Friday Sector Laggards: Biotechnology, Drugs
NASDAQ · 11/15 17:15
Aileron Therapeutics GAAP EPS of -$0.27 misses by $0.02
Seeking Alpha · 11/15 11:39
Based on the provided financial report, the title of the article is: "Aileron Therapeutics, Inc. Reports Financial Results for the Quarter Ended September 30, 2024
Press release · 11/14 23:29
AILERON THERAPEUTICS, INC. Q3 EPS USD -0.27
Reuters · 11/14 21:15
*Aileron Therapeutics 3Q Loss $5.85M >ALRN
Dow Jones · 11/14 21:15
Aileron Therapeutics' Investigational Drug Shows Encouraging Action In Lung Fibrosis
Benzinga · 11/13 18:04
Aileron Therapeutics Reports Positive Phase 1b Data Of LTI-03 In Idiopathic Pulmonary Fibrosis
NASDAQ · 11/13 12:36
More
About ALRN
Aileron Therapeutics, Inc. is a biopharmaceutical company. The Company is advancing a pipeline of medicines to address unmet medical needs in orphan pulmonary and fibrosis indications. Its lead product candidate, LTI-03, is a synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. LTI-03 is being evaluated in a Phase Ib clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Its second product candidate, LTI-01, is a proenzyme, or zymogen, designed to slowly activate in the pleural space and break up the scar tissue, allowing for drainage of the pleural effusion. It has completed Phase Ib and Phase IIa clinical trials for the treatment of loculated pleural effusions.

Webull offers Aileron Therapeutics Inc stock information, including NASDAQ: ALRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALRN stock methods without spending real money on the virtual paper trading platform.